Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1661-1670 of 9365

Page
per page
  1. LY3009120
    A8716 LY3009120
    Target: Raf
    Summary: pan-RAF and RAF dimer inhibitor
      insoluble in H2O; insoluble in EtOH; ≥4.25 mg/mL
  2. SBI-0206965
    A8715 SBI-0206965
     2 Citation
    Target: ULK1
    Summary: ULK1 inhibitor
      ≥24.47 mg/mL
  3. SR-9243
    A8714 SR-9243
    Target: Liver X receptors (LXRs)
    Summary: inverse agonist of LXR
      ≥25.2 mg/mL
  4. LFM-A13
    B5952 LFM-A13
    Summary: BTK-specific tyrosine kinase inhibitor
      ≥36 mg/mL
  5. SCH772984 TFA
    B5867 SCH772984 TFA
    Summary: ERK1/2 inhibitor
      ≥26.1 mg/mL
  6. SCH772984 HCl
    B5866 SCH772984 HCl
    Summary: ERK1/2 inhibitor
      ≥23.5 mg/mL
  7. GSK J4 free base
    B5959 GSK J4 free base
    Summary: histone demethylase JMJD3/UTX inhibitor
  8. Boc-Lys(Ac)-AMC
    A8713 Boc-Lys(Ac)-AMC
     1 Citation
    Summary: GPCR G2A/GPR132 agonist
  9. Pexidartinib (PLX3397)
    B5854 Pexidartinib (PLX3397)
     3 Citation
    Target: FLT3|c-Kit|CSF1R
    Summary: A multi-targeted receptor tyrosine kinase inhibitor; A CSF-1R inhibitor
      insoluble in EtOH; insoluble in H2O; ≥20.9 mg/mL
  10. GSK1349572 sodiuM salt
    B5856 GSK1349572 sodiuM salt
    Summary: Next-generation HIV integrase (IN) inhibitor
      insoluble in H2O; insoluble in EtOH; ≥8.06 mg/mL

Items 1661-1670 of 9365

Page
per page